Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Konstantinos Bartziokas"'
Autor:
Anastasia Papaporfyriou, Konstantinos Bartziokas, Ioulianos Apessos, Jan Mueller, Vasileios Leivaditis, Efstratios Koletsis, Konstantinos Grapatsas
Publikováno v:
Current Oncology, Vol 31, Iss 10, Pp 6289-6299 (2024)
Non-small cell lung cancer (NSCLC) remains a leading cause of cancer-related mortality worldwide. Immunotherapy has emerged as a promising treatment option due to its favorable toxicity profile. However, selecting the most appropriate immunotherapeut
Externí odkaz:
https://doaj.org/article/ef2c3b34cb5445f59b491e2276a2607f
Autor:
Paschalis Steiropoulos, Niki Georgatou, George Krommidas, Konstantinos Bartziokas, Aliki Korkontzelou, Panos Katerelos, Petros Efstathopoulos, Dimosthenis Papapetrou, Stavros Theodorakis, Konstantinos Porpodis
Publikováno v:
Therapeutic Advances in Respiratory Disease, Vol 18 (2024)
Background: The extrafine single inhaler triple therapy (efSITT) containing beclomethasone dipropionate/formoterol fumarate/glycopyrronium 87/5/9 μg has proved to be efficacious in patients with chronic obstructive pulmonary disease (COPD) in random
Externí odkaz:
https://doaj.org/article/e975f8ded37a407883f43506c3346a27
Autor:
Konstantinos Bartziokas, Andriana I. Papaioannou, Fotios Drakopanagiotakis, Evanthia Gouveri, Nikolaos Papanas, Paschalis Steiropoulos
Publikováno v:
Biomedicines, Vol 12, Iss 2, p 437 (2024)
Evidence from large epidemiological studies has shown that obesity may predispose to increased Th2 inflammation and increase the odds of developing asthma. On the other hand, there is growing evidence suggesting that metabolic dysregulation that occu
Externí odkaz:
https://doaj.org/article/54de20a3c38e419984659d8405f54583
Autor:
Anastasia Papaporfyriou, Konstantinos Bartziokas, Daniela Gompelmann, Marco Idzko, Evangelia Fouka, Stavrina Zaneli, Petros Bakakos, Stelios Loukides, Andriana I. Papaioannou
Publikováno v:
Life, Vol 13, Iss 6, p 1299 (2023)
Chronic obstructive pulmonary disease (COPD) is considered one of the leading causes of mortality. Cardiovascular comorbidities are diagnosed often in COPD patients, not only because of the common risk factors these two diseases share, but also becau
Externí odkaz:
https://doaj.org/article/0f0290b9a13b4d1fbc9a098732249810
Publikováno v:
ERJ Open Research, Vol 7, Iss 2 (2021)
Currently, and based on the development of relevant biologic therapies, T2-high is the most well-defined endotype of asthma. Although much progress has been made in elucidating T2-high inflammation pathways, no specific clinically applicable biomarke
Externí odkaz:
https://doaj.org/article/7daf183783d548cd86912cf933ea93bf
Autor:
Alexander G. Mathioudakis, Fekri Abroug, Alvar Agusti, Per Bakke, Konstantinos Bartziokas, Bianca Beghe, Andras Bikov, Thomas Bradbury, Guy Brusselle, Cordula Cadus, Courtney Coleman, Marco Contoli, Alexandru Corlateanu, Olga Corlateanu, Gerard Criner, Balazs Csoma, Alexander Emelyanov, Rosa Faner, Gustavo Fernandez Romero, Zeineb Hammouda, Peter Horváth, Arturo Garcia Huerta, Michael Jacobs, Christine Jenkins, Guy Joos, Olga Kharevich, Konstantinos Kostikas, Elena Lapteva, Zsofia Lazar, Joerg D. Leuppi, Carol Liddle, Alejandra López-Giraldo, Vanessa M. McDonald, Rune Nielsen, Alberto Papi, Isabel Saraiva, Galina Sergeeva, Agni Sioutkou, Pradeesh Sivapalan, Elizabeth Stovold, Hao Wang, Fuqiang Wen, Janelle Yorke, Paula R. Williamson, Jørgen Vestbo, Jens-Ulrik Jensen
Publikováno v:
ERJ Open Research, Vol 6, Iss 3 (2020)
Randomised controlled trials (RCTs) on the management of COPD exacerbations evaluate heterogeneous outcomes, often omitting those that are clinically important and patient relevant. This limits their usability and comparability. A core outcome set (C
Externí odkaz:
https://doaj.org/article/dfd93fb33a6f40418e55324396098562
Autor:
Konstantinos Bartziokas, Christos Kyriakopoulos, Dimitrios Potonos, Konstantinos Exarchos, Athena Gogali, Konstantinos Kostikas
Publikováno v:
Diagnostics, Vol 12, Iss 1, p 193 (2022)
Background: Uric acid (UA) is the final product of purine metabolism and a marker of oxidative stress that may be involved in the pathophysiology of cardiovascular and thromboembolic disease. The aim of the current study is to investigate the potenti
Externí odkaz:
https://doaj.org/article/f6312dfabdef4b70b2f6b0661bafede5
Publikováno v:
COPD: Journal of Chronic Obstructive Pulmonary Disease. 18:690-699
Blood eosinophils have been proposed as a surrogate biomarker of airway eosinophilia that can be used for treatment decisions in patients with COPD, mainly for the identification of candidates for the initiation or withdrawal of therapy with inhaled
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0aeec9bd6f4c3c3ba012194c9ae369d6
https://doi.org/10.1080/15412555.2021.1985989
https://doi.org/10.1080/15412555.2021.1985989
Autor:
Konstantinos Porpodis, Konstantinos Bartziokas, Panagiotis Chatziapostolou, Aliki Korkontzelou, Panos Katerelos, Petros Efstathopoulos, Petros Bakakos
Publikováno v:
Respiratory Medicine. 212:107219
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e1993b6e414bae79d3433fe2035971d0
https://doi.org/10.1016/j.rmed.2023.107219
https://doi.org/10.1016/j.rmed.2023.107219
Autor:
Konstantinos Bartziokas, Evangelia Fouka, Stelios Loukides, Paschalis Steiropoulos, Petros Bakakos, Andriana I. Papaioannou
Publikováno v:
Journal of personalized medicine. 12(10)
IL-26 is a cytokine expressed by infiltrating pro-inflammatory IL-17-producing T cells in the tissues of patients with chronic lung inflammation. IL-26 induces the chemotactic response of human neutrophils to bacteria and other inflammatory stimuli.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f027a2c9c9d5934ea261f220365000d
https://pubmed.ncbi.nlm.nih.gov/36294822
https://pubmed.ncbi.nlm.nih.gov/36294822